medium
Buy
13,000 shares
$235,768
Significance
6/10
Director Robert J. Hombach buys 13,000 shares of SPTX at $18.14 for $235.8K; first position, amid -$25.4M net loss
Robert J. Hombach, a Director, completed his first purchase of Seaport Therapeutics stock, acquiring 13,000 shares at $18.14 on 2026-06-22 for $235.8K. The purchase occurs while the company reported net income of -$25,408,000.00, indicating significant operating losses. The stock currently trades at $18.97, 8.4% above the 30-day average, but 17.5% below its 52-week high of $23.00, positioning this buy within a compressed valuation zone. This inaugural Director purchase of material size warrants monitoring to assess whether it reflects confidence in Seaport's near-term trajectory or commercialization milestones.